{ "@context": "https://schema.org", "@graph": [ { "@type": "LegalCase", "@id": "case-9458", "postId": 9458, "name": "Microvast Holdings, Inc.", "description": "Faruqi & Faruqi, LLP Securities Litigation Partner\u00a0James (Josh) Wilson\u00a0Encourages Investors Who Suffered Losses In Microvast To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in\u00a0Microvast\u00a0between April 1, 2025 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner\u00a0Josh Wilson directly\u00a0at\u00a0877-247-4292\u00a0or\u00a0212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Microvast Holdings, Inc. (\u201cMicrovast\u201d or the \u201cCompany\u201d) (NASDAQ: MVST) and reminds investors of the\u00a0September 21, 2026 deadline\u00a0to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) due to, inter alia, inventory management issues and delays in commercial vehicle rollouts by Microvast’s customers, Defendants had overstated Microvast’s ability to reach its margin targets; (ii) Defendants overstated Microvast’s ability to complete the Huzhou Phase 3.2 expansion by the end of 2025; and (iii) as a result, Defendants’ public statements were materially false and misleading at all relevant times. Lead Plaintiff Deadline: September 21, 2026 \u00a0Call\u00a0Partner Josh Wilson\u00a0at\u00a0877-247-4292\u00a0or\u00a0212-983-9330 (Ext. 1310) Or\u00a0submit your information below\u00a0to learn about your rights.", "identifier": "MVST", "legal": { "court": "Southern District of Texas", "jurisdiction": "Federal (United States), federal securities laws" }, "classPeriod": { "start": "04/01/2025", "end": "03/16/2026" }, "leadPlaintiffDeadline": "09/21/2026", "caseStatus": { "name": "", "slug": "" }, "practiceArea": { "name": "Securities Litigation", "slug": "securities-litigation" }, "url": "https://faruqilaw.com/case/microvast-holdings-inc/", "canonicalUrl": "https://faruqilaw.com/case/microvast-holdings-inc/", "datePublished": "2026-07-21T21:48:25+00:00", "dateModified": "2026-07-22T14:18:07+00:00", "associatedOrganization": { "@id": "case-9458-org" }, "legalService": { "@id": "case-9458-legalservice" }, "hasPart": [ { "@id": "case-9458-faq" }, { "@id": "case-9458-press-list" } ], "legalRepresentation": [ { "@id": "case-9458-attorney-506" }, { "@id": "case-9458-attorney-516" } ] }, { "@type": "Organization", "@id": "case-9458-org", "name": "Microvast Holdings, Inc.", "identifier": "MVST", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "url": "https://microvast.com/" }, { "@type": "LegalService", "@id": "case-9458-legalservice", "name": "Faruqi & Faruqi, LLP", "url": "https://faruqilaw.com/", "telephone": "+1-212-983-9330", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "address": { "@type": "PostalAddress", "streetAddress": "685 3rd Ave 26th Floor", "addressLocality": "New York", "postalCode": "10017", "addressRegion": "NY", "addressCountry": "US" }, "sameAs": [ "https://faruqilaw.com/", "https://maps.google.com/?cid=3247549158190754383" ] }, { "@type": "Person", "@id": "case-9458-attorney-506", "name": "Robert W. Killorin", "worksFor": { "@id": "case-9458-legalservice" } }, { "@type": "Person", "@id": "case-9458-attorney-516", "name": "James M. Wilson, Jr.", "worksFor": { "@id": "case-9458-legalservice" } }, { "@type": "FAQPage", "@id": "case-9458-faq", "mainEntity": [ { "@type": "Question", "name": "What is the Microvast securities class action lawsuit about?", "acceptedAnswer": { "@type": "Answer", "text": "The lawsuit alleges that Microvast Holdings, Inc. (NASDAQ: MVST) made materially false and misleading statements about its business, operations, and compliance policies during the class period. Specifically, the complaint alleges that Microvast overstated its ability to reach margin targets and complete a key manufacturing expansion, resulting in harm to investors who purchased shares during that time." } }, { "@type": "Question", "name": "What is the class period for the Microvast MVST securities lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "The class period runs from April 1, 2025 through March 16, 2026. Investors who purchased or acquired Microvast shares during this window may be eligible to participate in the litigation." } }, { "@type": "Question", "name": "What false statements does the Microvast lawsuit allege were made?", "acceptedAnswer": { "@type": "Answer", "text": "The lawsuit alleges that Microvast defendants made false or misleading statements on two main fronts: that they overstated the company's ability to reach its margin targets, and that they overstated Microvast's ability to complete the Huzhou Phase 3.2 manufacturing expansion by the end of 2025. Inventory management issues and delays in commercial vehicle rollouts by Microvast's customers are cited as factors the company allegedly failed to adequately disclose." } }, { "@type": "Question", "name": "Why does the Microvast lawsuit say the company couldn't hit its margin targets?", "acceptedAnswer": { "@type": "Answer", "text": "The complaint alleges that inventory management issues and delays in commercial vehicle rollouts by Microvast's customers undermined the company's ability to reach its stated margin targets. Defendants allegedly failed to disclose these headwinds, causing public statements about the company's financial outlook to be materially misleading." } }, { "@type": "Question", "name": "What is the Huzhou Phase 3.2 expansion and why does it matter to the Microvast lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "The Huzhou Phase 3.2 expansion is a manufacturing capacity project that Microvast allegedly claimed it could complete by the end of 2025. The lawsuit alleges that defendants overstated the company's ability to finish this expansion on schedule, and that those statements were materially false and misleading to investors." } }, { "@type": "Question", "name": "Which court is handling the Microvast securities class action?", "acceptedAnswer": { "@type": "Answer", "text": "The case has been filed in the United States District Court for the Southern District of Texas. Investors with questions about the litigation or their eligibility to participate should consult with a securities attorney familiar with the case." } }, { "@type": "Question", "name": "Who can join the Microvast MVST class action lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "Investors who purchased or acquired shares of Microvast Holdings, Inc. (NASDAQ: MVST) between April 1, 2025 and March 16, 2026 may be potential class members. If you suffered losses on your Microvast investment during this period, you may have legal rights and should consider speaking with a securities litigation attorney." } }, { "@type": "Question", "name": "What do I need to do to be included in the Microvast class action?", "acceptedAnswer": { "@type": "Answer", "text": "In most securities class actions, investors do not need to take any action to be included as a class member if they purchased shares during the class period. However, investors who wish to be considered for the lead plaintiff role must file a motion with the court by the applicable deadline, and should consult a securities attorney promptly to understand their options." } } ] }, { "@type": "NewsArticle", "@id": "case-9458-press-1", "headline": "MVST Stock Is Down 46% This Year and a $32.5M Inventory Hit Explains a Lot", "url": "https://247wallst.com/investing/2026/03/20/mvst-stock-is-down-46-this-year-and-a-32-5m-inventory-hit-explains-a-lot/", "datePublished": "2026-03-20" }, { "@type": "NewsArticle", "@id": "case-9458-press-2", "headline": "Microvast Stock Slides On Q4 Earnings Miss", "url": "https://www.benzinga.com/trading-ideas/movers/26/03/51299960/microvast-stock-slides-on-q4-earnings-miss", "datePublished": "2026-03-17" }, { "@type": "NewsArticle", "@id": "case-9458-press-3", "headline": "Microvast: Growth Story At Risk As Backlog Continues To Shrink", "url": "https://seekingalpha.com/article/4884477-microvast-growth-story-at-risk-as-backlog-continues-to-shrink", "datePublished": "2026-03-16" }, { "@type": "NewsArticle", "@id": "case-9458-press-4", "headline": "Microvast Shares Are Down: What's Going On?", "url": "https://www.benzinga.com/trading-ideas/movers/25/03/44406011/microvast-shares-are-down-whats-going-on", "datePublished": "2025-03-19" }, { "@type": "NewsArticle", "@id": "case-9458-press-5", "headline": "Why Microvast Holdings (MVST) Is Plunging in 2025?", "url": "https://finance.yahoo.com/news/why-microvast-holdings-mvst-plunging-074148156.html", "datePublished": "2025-03-17" }, { "@type": "ItemList", "@id": "case-9458-press-list", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@id": "case-9458-press-1" } }, { "@type": "ListItem", "position": 2, "item": { "@id": "case-9458-press-2" } }, { "@type": "ListItem", "position": 3, "item": { "@id": "case-9458-press-3" } }, { "@type": "ListItem", "position": 4, "item": { "@id": "case-9458-press-4" } }, { "@type": "ListItem", "position": 5, "item": { "@id": "case-9458-press-5" } } ] } ] }

Microvast Holdings, Inc.

Microvast Holdings, Inc.

Join Action
Case Details
Ticker MVST
Class Period 04/01/2025 - 03/16/2026
Lead Plaintiff Deadline 09/21/2026
Days Left to Seek Lead Plaintiff
61

If you are a Microvast investor who suffered a loss and would like to learn more, you can provide your information below:

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Microvast To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Microvast between April 1, 2025 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Microvast Holdings, Inc. (“Microvast” or the “Company”) (NASDAQ: MVST) and reminds investors of the September 21, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) due to, inter alia, inventory management issues and delays in commercial vehicle rollouts by Microvast’s customers, Defendants had overstated Microvast’s ability to reach its margin targets; (ii) Defendants overstated Microvast’s ability to complete the Huzhou Phase 3.2 expansion by the end of 2025; and (iii) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

📞 Lead Plaintiff Deadline: September 21, 2026

💻 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.

Join Action
Microvast Holdings, Inc.
1
1
1
1

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Counsel
Robert W. Killorin
rkillorin@faruqilaw.com
Phone (404) 847-0617
Fax (404) 506-9534
James M. Wilson, Jr.
jwilson@faruqilaw.com
Phone (212) 983-9330
Fax (212) 983-9331
Office
New York
685 Third Avenue 26th Floor New York New York 10017
Phone (212) 983-9330
Fax (212) 983-9331

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771